YU42796A - Pharamaceutical preparation containing ypriflavone, appropriate for the reduction of cd8+cells - Google Patents
Pharamaceutical preparation containing ypriflavone, appropriate for the reduction of cd8+cellsInfo
- Publication number
- YU42796A YU42796A YU42796A YU42796A YU42796A YU 42796 A YU42796 A YU 42796A YU 42796 A YU42796 A YU 42796A YU 42796 A YU42796 A YU 42796A YU 42796 A YU42796 A YU 42796A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- cells
- ypriflavone
- reduction
- appropriate
- preparation containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
Abstract
Predmetni pronalazak se odnosi na farmaceutski preparat podesan za smanjenje broja CD8+ ćelija koji obuhvata kao aktivni sastojak 7-izopropoksiizoflavon u smeši sa podesnim inertnim, čvrstim ili tečnim nosačima i po izboru sa uobičajenim terapeutskim aditivima i pomoćnim agensima. Farmacetuski preparati prema pronalasku se dobivaju poznatim postupcima i podesni su za tretiranje humanih i animalnih subjekata koji su u stanju gde se želi supresija CD8+ limfocita.The present invention relates to a pharmaceutical composition suitable for reducing the number of CD8 + cells comprising as active ingredient 7-isopropoxyisoflavone in admixture with suitable inert, solid or liquid carriers and optionally with customary therapeutic additives and auxiliary agents. The pharmaceutical compositions of the invention are prepared by known methods and are suitable for treating human and animal subjects in a condition where CD8 + lymphocyte suppression is desired.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9502198A HU9502198D0 (en) | 1995-07-21 | 1995-07-21 | Novel indication |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU42796A true YU42796A (en) | 1999-03-04 |
Family
ID=10987063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU42796A YU42796A (en) | 1995-07-21 | 1996-07-19 | Pharamaceutical preparation containing ypriflavone, appropriate for the reduction of cd8+cells |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0841915A1 (en) |
| JP (1) | JP2001503371A (en) |
| KR (1) | KR19990028933A (en) |
| CN (1) | CN1191483A (en) |
| AR (1) | AR002905A1 (en) |
| AU (1) | AU6367096A (en) |
| BG (1) | BG102182A (en) |
| BR (1) | BR9610187A (en) |
| CA (1) | CA2227421A1 (en) |
| CZ (1) | CZ2798A3 (en) |
| EA (1) | EA199800146A1 (en) |
| EE (1) | EE9800020A (en) |
| HR (1) | HRP960345A2 (en) |
| HU (1) | HU9502198D0 (en) |
| IL (1) | IL122751A0 (en) |
| MX (1) | MX9800603A (en) |
| NO (1) | NO980127L (en) |
| PL (1) | PL324460A1 (en) |
| SK (1) | SK3298A3 (en) |
| WO (1) | WO1997003664A1 (en) |
| YU (1) | YU42796A (en) |
| ZA (1) | ZA966079B (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1241079B (en) * | 1990-03-23 | 1993-12-29 | Chiesi Farma Spa | PHARMACEUTICAL COMPOSITIONS CONTAINING IPRIFLAVONE, PROCEDURE FOR THEIR PREPARATION AND RELATED THERAPEUTIC USE |
| HU212932B (en) * | 1993-08-02 | 1996-12-30 | Chinoin Gyogyszer Es Vegyeszet | Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition |
-
1995
- 1995-07-21 HU HU9502198A patent/HU9502198D0/en unknown
-
1996
- 1996-07-16 MX MX9800603A patent/MX9800603A/en unknown
- 1996-07-16 JP JP50646497A patent/JP2001503371A/en active Pending
- 1996-07-16 EA EA199800146A patent/EA199800146A1/en unknown
- 1996-07-16 WO PCT/HU1996/000038 patent/WO1997003664A1/en not_active Application Discontinuation
- 1996-07-16 SK SK32-98A patent/SK3298A3/en unknown
- 1996-07-16 EP EP96923004A patent/EP0841915A1/en not_active Withdrawn
- 1996-07-16 IL IL12275196A patent/IL122751A0/en unknown
- 1996-07-16 AU AU63670/96A patent/AU6367096A/en not_active Abandoned
- 1996-07-16 CN CN96195722A patent/CN1191483A/en active Pending
- 1996-07-16 PL PL96324460A patent/PL324460A1/en unknown
- 1996-07-16 CA CA002227421A patent/CA2227421A1/en not_active Abandoned
- 1996-07-16 BR BR9610187A patent/BR9610187A/en not_active Application Discontinuation
- 1996-07-16 CZ CZ9827A patent/CZ2798A3/en unknown
- 1996-07-16 KR KR1019980700235A patent/KR19990028933A/en not_active Application Discontinuation
- 1996-07-16 EE EE9800020A patent/EE9800020A/en unknown
- 1996-07-17 ZA ZA9606079A patent/ZA966079B/en unknown
- 1996-07-18 HR HRP9502198A patent/HRP960345A2/en not_active Application Discontinuation
- 1996-07-19 YU YU42796A patent/YU42796A/en unknown
- 1996-07-22 AR ARP960103677A patent/AR002905A1/en unknown
-
1998
- 1998-01-12 NO NO980127A patent/NO980127L/en unknown
- 1998-01-14 BG BG102182A patent/BG102182A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL324460A1 (en) | 1998-05-25 |
| JP2001503371A (en) | 2001-03-13 |
| HU9502198D0 (en) | 1995-09-28 |
| NO980127D0 (en) | 1998-01-12 |
| SK3298A3 (en) | 1998-07-08 |
| WO1997003664A8 (en) | 1999-08-05 |
| CN1191483A (en) | 1998-08-26 |
| MX9800603A (en) | 1998-04-30 |
| WO1997003664A1 (en) | 1997-02-06 |
| EA199800146A1 (en) | 1998-08-27 |
| KR19990028933A (en) | 1999-04-15 |
| AR002905A1 (en) | 1998-04-29 |
| CZ2798A3 (en) | 1998-06-17 |
| AU6367096A (en) | 1997-02-18 |
| IL122751A0 (en) | 1998-08-16 |
| ZA966079B (en) | 1998-01-19 |
| BG102182A (en) | 1998-08-31 |
| EP0841915A1 (en) | 1998-05-20 |
| NO980127L (en) | 1998-01-12 |
| CA2227421A1 (en) | 1997-02-06 |
| HRP960345A2 (en) | 1998-02-28 |
| EE9800020A (en) | 1998-08-17 |
| BR9610187A (en) | 1998-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU47543B (en) | PROCEDURE FOR OBTAINING PHARMACEUTICAL PREPARATION FOR GRANULLocyte Stimulation | |
| NO20005431L (en) | Gellable pharmaceutical preparations | |
| ATE469633T1 (en) | DENTAL CARE COMPOSITIONS | |
| DE60040753D1 (en) | THERAPEUTIC USES OF STEROIDS IN BLOOD CELL FAULT EXPOSURES | |
| MX9307509A (en) | Method and pharmaceutical preparation to reduce cell activity. | |
| ATE215827T1 (en) | IMMUNOLOGICAL ACTIVITY OF RHAMNOLIPIDS | |
| MD1688F2 (en) | Benzothiophene, benzofuran and indolethiazepinons, oxazepinons and diazepinons, pharmaceutical composition, method of inhibiting the leucocytes adherence to the endothelial cells for inflammatory diseases treatment and method of treatment of the mammals affected by the HIV infection | |
| DK284386D0 (en) | PHARMACEUTICAL PREPARATION FOR SKIN DISORDERS | |
| DE69805983D1 (en) | COUGH-RESISTANT COMPOSITIONS CONTAINING THEOBROMINE | |
| IT1170214B (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIPHERAL ARTERIOPATHIES | |
| ES8400076A1 (en) | Tricyclic cytosine derivatives for use in pharmaceutical preparations and process for their preparation. | |
| ES2134237T3 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING URSODESOXICOLICO ACID. | |
| DE69632396D1 (en) | TREATMENT OF DISEASES CAUSED BY THE CYTOKIN GROWTH FACTOR | |
| KR880007068A (en) | Use of 13-cis retinoic acid | |
| YU42796A (en) | Pharamaceutical preparation containing ypriflavone, appropriate for the reduction of cd8+cells | |
| HRP20060040A2 (en) | PURE D-(17α)-13-ETHYL-17-HYDROXY-18,19-DINORPREGN-4-ENE-20-YNE-3-ONE-3E- AND -3Z-OXIME ISOMERS, AS WELL AS PROCESS FOR THE SYNTHESIS OF THE MIXTURE OF ISOMERS AND THE PURE ISOMERS | |
| DK0981363T3 (en) | Somatostatin agonists for reducing body weight | |
| KR20040049068A (en) | Hair growth promotion composition | |
| WO1988007371A3 (en) | Prevention and treatment of the deleterious effects of exposing skin to the sun, and compositions therefor | |
| JPS61286327A (en) | External drug for topical administration | |
| ES2122010T3 (en) | AMYLINE MUTEINS. |